在阿尔茨海默氏病中,性别和大脑区域特定的基因表达
Ziyu Wan1, Xin Feng2, Jeff Chou3,4
1Department of Internal Medicine-Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Journal of Alzheimer's disease : JAD
|January 21, 2026
概括
阿尔茨海默病 (AD) 对女性的影响更为严重. 这项研究在男性和女性大脑中发现了不同的基因表达模式,揭示了对AD病原和个性化治疗策略的新见解.
科学领域:
- 神经科学是一个神经科学.
- 基因组学就是基因组学.
- 病理学 病理学 病理学
背景情况:
- 与男性相比,女性患阿尔茨海默病 (AD) 的患病率和严重程度更高.
- 性别之间阿尔茨海默病对大脑区域的影响差异表明了潜在的机制差异.
- 目前对性别特异性AD病原体的理解仍然有限.
研究的目的:
- 研究阿尔茨海默病 (AD) 大脑中的性别依赖和区域特定的基因表达特征.
- 以特定性别的方式识别导致AD病理的新型分子机制.
- 奠定AD个性化诊断和治疗方法的基础.
主要方法:
- 利用来自19个皮层区域的死后大脑样本的大规模批量组织基因表达数据集.
- 进行了差异性基因表达分析,将正常对照组与被诊断为AD的个体进行比较.
- 通过Western blot进行了功能性丰富分析并验证了蛋白质表达.
主要成果:
- 在11个AD大脑区域中确定了113个失调的基因,在女性 (77) 发现的基因比男性 (49) 更多.
- 在这些地区发现了13个性别之间共享的失调基因.
- 在多个区域的男性AD脑样本中观察到高调的GPR34基因和蛋白质表达.
结论:
- 这项研究强调了阿尔茨海默病中性别和大脑区域特定的显著基因表达失调.
- 这些发现表明,AD病原体的基础是新的机制.
- 结果有助于开发个性化的AD诊断和治疗策略.
相关概念视频
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35